Clinical evaluation
A healthcare professional reviews symptoms, bowel changes, bleeding, anemia, family history, previous polyps, inflammatory bowel disease and risk factors.
Colon cancer diagnosis and staging help confirm whether cancer is present, identify the tumor type, evaluate how far it has grown or spread, and provide essential information for clinical decision-making.
Diagnosis usually begins when symptoms, screening results, blood test findings or imaging results suggest a possible colon abnormality. Confirmation typically requires examination of tissue by pathology.
A healthcare professional reviews symptoms, bowel changes, bleeding, anemia, family history, previous polyps, inflammatory bowel disease and risk factors.
Colonoscopy allows direct inspection of the colon and can be used to remove polyps or take biopsies from suspicious areas.
Pathology confirms the cancer type, while staging evaluates tumor depth, lymph node involvement and spread to distant organs.
The exact diagnostic pathway depends on symptoms, screening results, age, risk factors and clinical findings. The following steps are commonly involved.
Symptoms such as blood in stool, bowel habit changes, abdominal pain, fatigue or unexplained weight loss are reviewed along with personal and family risk factors.
Blood tests may detect anemia or other abnormalities. Stool-based tests may detect hidden blood or molecular signals, but abnormal results usually need follow-up evaluation.
Colonoscopy examines the inside of the colon using a flexible camera. It can identify polyps, masses, inflammation or bleeding sites and allows tissue sampling.
A biopsy provides tissue for microscopic examination. Pathology can confirm whether cancer is present and identify histological features such as adenocarcinoma.
CT, MRI, PET/CT or other imaging may be used to evaluate spread. Molecular testing may assess markers such as mismatch repair status, MSI, KRAS, NRAS, BRAF or other clinically relevant features.
Diagnostic and staging tests help locate abnormalities, confirm cancer, classify tumor biology and evaluate whether cancer has spread.
Directly examines the colon and allows biopsy or polyp removal when appropriate.
Provides tissue for microscopic examination and confirmation of cancer type.
Describes tumor type, grade, invasion depth, lymph node findings and other features.
May help detect anemia, organ function changes or baseline health information.
Often used to evaluate the abdomen, pelvis, chest and possible spread to other organs.
May be used in selected colorectal cancer contexts, especially detailed pelvic evaluation.
May be used in selected cases to evaluate metabolically active disease or clarify findings.
May evaluate mismatch repair, MSI, KRAS, NRAS, BRAF and other tumor markers.
Staging describes how far colon cancer has grown or spread. It helps clinicians understand the extent of disease and compare cancers using a standardized system.
Describes how deeply the primary tumor has grown into or through the colon wall.
Describes whether cancer has spread to nearby lymph nodes and how many are involved.
Describes whether cancer has spread to distant organs such as the liver, lungs, peritoneum or distant lymph nodes.
Colon cancer is often described from stage 0 to stage IV. The exact stage depends on detailed TNM findings and pathology review.
Very early cancer cells are found in the innermost lining and have not grown into deeper layers of the colon wall.
Cancer has grown into deeper layers of the colon wall but has not spread to nearby lymph nodes or distant organs.
Cancer has grown through or beyond the colon wall but has not spread to nearby lymph nodes.
Cancer has spread to nearby lymph nodes but has not spread to distant organs.
Cancer has spread to distant organs or tissues, such as the liver, lungs, peritoneum or distant lymph nodes.
A pathology report summarizes microscopic findings from biopsy or surgery. It may include tumor type, grade, invasion depth, lymph node findings and molecular or immunohistochemistry results.
Most colon cancers are adenocarcinomas, but pathology confirms the exact tumor type.
Grade describes how abnormal the cancer cells look under the microscope.
In surgical specimens, margins describe whether cancer cells are present at the edge of removed tissue.
Removed lymph nodes may be examined to see whether cancer has spread to them.
Biomarker testing can help describe colon tumor biology. The specific tests used depend on clinical context, tumor stage, pathology findings and local guidelines.
Mismatch repair and microsatellite instability testing evaluates DNA repair-related tumor biology.
RAS pathway alterations are commonly assessed in colorectal cancer molecular profiling.
BRAF status may provide information about tumor biology and molecular subtype.
HER2 alterations may be evaluated in selected colorectal cancer contexts.
NTRK fusion testing may be considered in selected molecular testing workflows.
Carcinoembryonic antigen is widely discussed in colorectal cancer monitoring and research literature.
These terms are related but not identical. Screening looks for disease before symptoms. Diagnosis confirms whether cancer is present. Staging describes how far confirmed cancer has spread.
Used in people who may feel well, with the goal of finding polyps or cancer early.
Used to find the cause of symptoms or abnormal screening results and confirm disease.
Used after diagnosis to evaluate tumor extent, lymph nodes and distant spread.
Diagnosis confirms whether colon cancer is present. Staging explains how far it has grown or spread. Together, these results help clinicians understand the disease more clearly.
Colon cancer is usually confirmed by examining tissue from a biopsy or removed lesion under a microscope.
TNM staging describes the primary tumor, nearby lymph nodes and distant metastasis. These findings are combined to assign a stage group.
Molecular testing can identify features such as mismatch repair deficiency, microsatellite instability, RAS pathway alterations or other tumor markers that describe tumor biology.
Clear answers to common questions about colonoscopy, biopsy, pathology, TNM staging and molecular testing.
Colon cancer is diagnosed using clinical evaluation, colonoscopy, biopsy and pathology review. Imaging and molecular testing may also be used depending on the case.
Yes. Colonoscopy can examine the inside of the colon and allows biopsy or polyp removal when suspicious tissue is found.
Staging describes how far cancer has grown into the colon wall, whether nearby lymph nodes are involved and whether cancer has spread to distant organs.
TNM staging describes the primary tumor, nearby lymph node involvement and distant metastasis. These details are combined to assign a stage group.
Colon cancer is commonly grouped as stage 0, stage I, stage II, stage III and stage IV. Higher stages generally indicate that cancer has grown further or spread more.
No. This page is educational only and does not replace consultation with a qualified healthcare professional.
Authoritative sources used to support the colon cancer diagnosis and staging content.